# Pfizer Inc. (PFE) — Q3-2022 Earnings Results

**Report date:** 2022-11-01 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2022

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 3.14%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.78 | N/A | +21.09% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings beat on EPS. They emphasized their commitment to maintaining shareholder value.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Pfizer's strong EPS performance indicates effective cost management and operational efficiency, contributing to a positive stock reaction of 3.14%. Investors may view this earnings beat as a sign of resilience in a challenging market. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2022_